Drug Safety Surveillance: Modern Trends and Industrial Action

Abubakar, Abdullahi Rabiu and Simbak, Nordin and Haque , Mainul (2015) Drug Safety Surveillance: Modern Trends and Industrial Action. Journal of Young Pharmacists, 7 (2). pp. 69-75. ISSN 0975-1575

[img] Text
Restricted to Registered users only

Download (391Kb) | Request a copy
Official URL: http://www.jyoungpharm.org/


The primary aim of patient care is to provide the best medication that can produce the best treatment with minimal or no harm. This is only possible when the entire health care workers play their card well through correct prescription, dispensing, drug administration and adequate patient monitoring. However, the outcome is not always favorable because of the limited time undergone by the drug during premarketing studies as well as the bias by the pharmaceutical-industries to get approval from regulatory-agencies. As a result of this many safety data and information are lacking. Therefore, in order to preserve patient confidence and integrity of pharmaceutical products, post-marketing surveillance has become necessary. The methods commonly used in post-marketing surveillance include spontaneous reporting, data mining and active reporting which have meaningfully contributed to patient safety. Despite the improvement made, spontaneous reporting have some disadvantages such as underreporting, poor quality of reports, and cannot be used to determine risk rate. Pharmaceutical companies as owners of the drug have noteworthy role to play in adverse drug reactions monitoring and can adopt similar techniques used by the regulatory-agencies and academic research. Unfortunately, this has led to reporting bias. This has suggested the need for more awareness and educational intervention for health care professionals at all levels. The curriculum of training medical and health related students should be incorporated with PV programme. This appraisal has described how to identify adverse drug reactions and methods used in reporting, current developments in pharmacovigilance and role of pharmaceutical-industries in drug safety studies.

Item Type: Article
Keywords: Patient-safety, Pharmacovigilance, Pharmaceutical-industries, Spontaneous-Reporting
Subjects: R Medicine > RM Therapeutics. Pharmacology
Faculty / Institute: Faculty of Medicine
Depositing User: Professor Dr Mainul Haque
Date Deposited: 03 Mar 2015 08:03
Last Modified: 30 Apr 2015 06:48
URI: http://erep.unisza.edu.my/id/eprint/3076

Actions (login required)

View Item View Item